TGFB1 and idiopathic pulmonary fibrosis: Pirfenidone decelerates fibrosis by inhibiting pro-fibrotic and pro-inflammatory cytokine cascades, including TGF-β signaling, which plays a central role in IPF pathogenesis [53].